FIGS (NYSE:FIGS – Get Free Report) is anticipated to release its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect FIGS to post earnings of $0.0706 per share and revenue of $182.82 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.
FIGS (NYSE:FIGS – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.08. FIGS had a return on equity of 12.53% and a net margin of 8.72%. The firm had revenue of $196.62 million during the quarter, compared to analysts’ expectations of $186.17 million. During the same period in the previous year, the firm earned $0.04 EPS. The company’s quarterly revenue was up 28.8% compared to the same quarter last year. On average, analysts expect FIGS to post $0.32 EPS for the current fiscal year and $0.36 EPS for the next fiscal year.
FIGS Stock Performance
Shares of NYSE FIGS traded down $0.46 during mid-day trading on Tuesday, reaching $20.83. The company had a trading volume of 244,984 shares, compared to its average volume of 3,302,959. FIGS has a one year low of $7.31 and a one year high of $22.46. The firm has a market cap of $3.46 billion, a price-to-earnings ratio of 63.09 and a beta of 1.06. The business’s 50-day simple moving average is $15.90 and its 200 day simple moving average is $13.46.
Wall Street Analyst Weigh In
FIGS has been the topic of a number of recent analyst reports. KeyCorp lifted their price objective on shares of FIGS from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Telsey Advisory Group reduced their price objective on FIGS from $17.00 to $16.00 and set a “market perform” rating on the stock in a research note on Friday, August 7th. Oppenheimer lifted their target price on FIGS from $22.00 to $25.00 and gave the company an “outperform” rating in a research report on Thursday. Barclays upped their price objective on shares of FIGS from $20.00 to $24.00 and gave the stock an “overweight” rating in a research report on Tuesday. Finally, Roth Capital reiterated a “buy” rating on shares of FIGS in a research report on Friday, August 7th. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.14.
Read Our Latest Stock Analysis on FIGS
About FIGS
FIGS, Inc is a direct-to-consumer healthcare apparel and lifestyle company that designs and sells clothing and accessories for healthcare professionals. Its product portfolio includes scrubs, underscrubs, outerwear, footwear, bags and other accessories intended to combine functionality, comfort and contemporary design.
The company sells primarily through its digital platform and also operates retail locations and other distribution channels. FIGS serves healthcare professionals in the United States and select international markets, including Canada, the United Kingdom and Australia.
FIGS was founded in 2013 by Heather Hasson and Trina Spear.
Further Reading
- Five stocks we like better than FIGS
- Caterpillar’s Sell-Off: Is the Market Missing Its AI Power Play?
- Check Point’s Turnaround Could Be Closer Than Investors Think
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
